Yatin Suneja Analyst PerformanceAnalyst at GuggenheimYatin Suneja is a stock analyst at Guggenheim focused in the healthcare sector, covering 48 publicly traded companies. Over the past year, Yatin Suneja has issued 91 stock ratings, including strong buy, buy, and hold recommendations. While full access to Yatin Suneja's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Yatin Suneja's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings171 Last 10 YearsBuy Recommendations87.72% 150 Buy RatingsCompanies Covered48 Unique Companies Ratings Distribution171RatingsDistribution of strong buy, buy, hold, and sell ratings by Yatin Suneja.RatingPercentageCount Strong Buy0.6%1 ratings Buy87.1%149 ratings Hold12.3%21 ratings Sell0.0%0 ratingsOut of 171 total stock ratings issued by Yatin Suneja at Guggenheim, the majority (87.1%) have been Buy recommendations, followed by 12.3% Hold and 0.6% Strong Buy.Best & Worst CallsBest Call000000.0%ABVXJul 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%AXSMApr 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ97.9% of companies on NASDAQ47 companiesNYSE2.1% of companies on NYSE1 companyYatin Suneja, an analyst at Guggenheim, currently covers 48 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare46 companies95.8%Miscellaneous2 companies4.2%Yatin Suneja of Guggenheim specializes in stock coverage within the Healthcare sector, with additional focus on companies.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY37 companies77.1%PHARMACEUTICALS9 companies18.8%Miscellaneous2 companies4.2% Yatin Suneja's Ratings History at Guggenheim Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsARGXargenex10/23/2026Lower Price Target$870.49$1,120.00Buy$0.0000.00% ROIABVXAbivax10/20/2026Reiterated Rating$87.49$175.00Buy$0.0000.00% ROIEYPTEyepoint Pharmaceuticals10/19/2026Downgrade$0.42Neutral$0.0000.00% ROIZBIOZenas BioPharma9/30/2026Reiterated Rating$26.76$55.00Buy$0.0000.00% ROIKRSACyclerion Therapeutics9/28/2026Initiated Coverage$31.00$70.00Buy$0.0000.00% ROITRAXFirst Tracks Biotherapeutics9/16/2026Initiated Coverage$38.47$100.00Buy$0.0000.00% ROITRAXFirst Tracks Biotherapeutics9/16/2026Initiated Coverage$38.47$100.00Buy$0.0000.00% ROITRAXFirst Tracks Biotherapeutics9/16/2026Initiated Coverage$39.00$100.00Buy$0.0000.00% ROIROIVRoivant Sciences9/9/2026Boost Price Target$41.48$46.00Buy$0.0000.00% ROIALMSAlumis9/3/2026Downgrade$10.35Neutral$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. LTGOLatigo Biotherapeutics9/1/2026Initiated Coverage$22.02$50.00Buy$0.0000.00% ROILTGOLatigo Biotherapeutics9/1/2026Initiated Coverage$22.26$50.00Buy$0.0000.00% ROIZBIOZenas BioPharma8/14/2026Reiterated Rating$29.04$55.00Buy$0.0000.00% ROIZURAZura Bio8/12/2026Boost Price Target$5.56$20.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics8/11/2026Boost Price Target$220.89$275.00Buy$0.0000.00% ROIORKAOruka Therapeutics8/11/2026Reiterated Rating$103.25$200.00Buy$0.0000.00% ROISIONSionna Therapeutics8/10/2026Downgrade$4.46Neutral$0.0000.00% ROIAVTXAvalo Therapeutics8/7/2026Set Price Target$18.70$48.00Buy$0.0000.00% ROISIONSionna Therapeutics8/7/2026Boost Price Target$49.61$60.00Buy$0.0000.00% ROIROIVRoivant Sciences8/7/2026Boost Price Target$36.09$42.00Buy$0.0000.00% ROIACETAdicet Bio8/6/2026Reiterated Rating$9.11$90.00Buy$0.0000.00% ROISYRESpyre Therapeutics8/5/2026Boost Price Target$106.85$130.00Buy$0.0000.00% ROISTOKStoke Therapeutics8/4/2026Reiterated Rating$30.07$60.00Buy$0.0000.00% ROIARGXargenex8/4/2026Initiated Coverage$844.27$1,185.00Buy$0.0000.00% ROIPHATPhathom Pharmaceuticals7/31/2026Lower Price Target$8.92$22.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences7/31/2026Boost Price Target$165.52$222.00Buy$0.0000.00% ROIARGXargenex7/24/2026Boost Price Target$924.08$1,185.00Buy$0.0000.00% ROIBIIBBiogen7/21/2026Boost Price Target$202.12$280.00Buy$0.0000.00% ROICLDXCelldex Therapeutics7/20/2026Boost Price Target$35.35$100.00Buy$0.0000.00% ROIEYPTEyepoint Pharmaceuticals6/24/2026Reiterated Rating$14.55$68.00Buy$0.0000.00% ROICLYMClimb Bio6/8/2026Initiated Coverage$10.55$35.00Buy$0.0000.00% ROICLYMClimb Bio6/8/2026Initiated Coverage$10.77$35.00Buy$0.0000.00% ROIOCSOculis6/1/2026Lower Price Target$22.70$45.00Buy$0.0000.00% ROIROIVRoivant Sciences5/26/2026Boost Price Target$29.96$36.00Buy$0.0000.00% ROIIMVTImmunovant5/26/2026Boost Price Target$34.15$62.00Buy$0.0000.00% ROIOCSOculis5/20/2026Initiated Coverage$27.91$75.00Buy$0.0000.00% ROIOCSOculis5/20/2026Upgrade$31.00Strong-Buy$0.0000.00% ROIALMSAlumis5/15/2026Boost Price Target$24.63$34.00Buy$0.0000.00% ROIARGXargenex5/8/2026Boost Price Target$787.31$1,135.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences5/6/2026Reiterated Rating$144.75$175.00Buy$0.0000.00% ROICrashGPT coming on Dec. 18 … (Ad)Sam Altman is expected to reveal a confidential OpenAI document around 4 p.m. on Dec. 18, just weeks before a potential IPO. The disclosure could trigger a 40 trillion dollar wealth shift. Altman himself has warned that someone is going to lose a phenomenal amount of money while others gain just as much.Watch the video to learn how to prepare for this eventAXSMAxsome Therapeutics5/4/2026Boost Price Target$227.50$260.00Buy$0.0000.00% ROIDBVTDBV Technologies5/4/2026Reiterated Rating$19.10$51.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals5/1/2026Boost Price Target$704.44$995.00Buy$0.0000.00% ROIBIIBBiogen4/30/2026Boost Price Target$194.38$260.00Buy$0.0000.00% ROIORKAOruka Therapeutics4/27/2026Set Price Target$80.91$200.00Buy$0.0000.00% ROIIFRXInflaRx4/21/2026Reiterated Rating$1.63$14.00Buy$0.0000.00% ROIORKAOruka Therapeutics4/13/2026Reiterated Rating$61.89$125.00Buy$0.0000.00% ROINMRANeumora Therapeutics3/31/2026Reiterated Rating$1.93$14.00Buy$0.0000.00% ROIDBVTDBV Technologies3/27/2026Reiterated Rating$20.21$51.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics3/25/2026Boost Price Target$158.75$245.00Buy$0.0000.00% ROIIMUXImmunic3/24/2026Initiated Coverage$11.70$70.00Buy$0.0000.00% ROICABACabaletta Bio3/24/2026Boost Price Target$2.70$16.00Buy$0.0000.00% ROIIFRXInflaRx3/20/2026Lower Price Target$0.91$14.00Buy$0.0000.00% ROIZBIOZenas BioPharma3/16/2026Boost Price Target$23.23$55.00Buy$0.0000.00% ROIORKAOruka Therapeutics3/13/2026Reiterated Rating$31.99$60.00Buy$0.0000.00% ROIACETAdicet Bio3/13/2026Lower Price Target$7.04$100.00Buy$0.0000.00% ROIXENEXenon Pharmaceuticals3/9/2026Reiterated Rating$62.63$90.00Buy$0.0000.00% ROISIONSionna Therapeutics3/2/2026Boost Price Target$33.68$50.00Buy$0.0000.00% ROIARGXargenex2/27/2026Lower Price Target$771.53$1,120.00Buy$0.0000.00% ROIPHATPhathom Pharmaceuticals2/27/2026Boost Price Target$12.94$25.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics2/24/2026Boost Price Target$174.76$220.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines2/10/2026Reiterated Rating$319.54$800.00Buy$0.0000.00% ROIBIIBBiogen2/9/2026Boost Price Target$201.18$246.00Buy$0.0000.00% ROIIMVTImmunovant2/9/2026Boost Price Target$27.05$44.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals2/9/2026Boost Price Target$784.43$975.00Buy$0.0000.00% ROISTOKStoke Therapeutics2/5/2026Initiated Coverage$32.00$60.00Buy$0.0000.00% ROISTOKStoke Therapeutics2/5/2026Initiated Coverage$32.40$60.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics2/2/2026Initiated Coverage$15.11$50.00Buy$0.0000.00% ROIRAPTRapt Therapeutics1/20/2026Downgrade$57.52Neutral$0.0000.00% ROIALMSAlumis1/7/2026Boost Price Target$16.23$32.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics1/2/2026Reiterated Rating$177.09$205.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines12/29/2025Reiterated Rating$301.40Buy$0.0000.00% ROISABSSAB Biotherapeutics12/19/2025Initiated Coverage$3.95$15.00Buy$0.0000.00% ROISABSSAB Biotherapeutics12/19/2025Initiated Coverage$3.84$15.00Buy$0.0000.00% ROIIMVTImmunovant12/18/2025Reiterated Rating$26.98$41.00Buy$0.0000.00% ROIANABAnaptysBio12/18/2025Reiterated Rating$45.60Buy$0.0000.00% ROIABVXAbivax12/18/2025Reiterated Rating$110.82$175.00Buy$0.0000.00% ROIDBVTDBV Technologies12/17/2025Reiterated Rating$17.98$51.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines12/9/2025Reiterated Rating$270.98$760.00Buy$0.0000.00% ROIDBVTDBV Technologies12/3/2025Initiated Coverage$12.90$35.00Buy$0.0000.00% ROIDBVTDBV Technologies12/3/2025Initiated Coverage$12.99$35.00Buy$0.0000.00% ROIROIVRoivant Sciences11/14/2025Reiterated Rating$20.56$25.00Buy$0.0000.00% ROIIFRXInflaRx11/10/2025Boost Price Target$1.23$22.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines11/6/2025Reiterated Rating$172.35$540.00Buy$0.0000.00% ROIANABAnaptysBio11/5/2025Boost Price Target$36.13$100.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics11/4/2025Boost Price Target$134.39$205.00Buy$0.0000.00% ROIPHATPhathom Pharmaceuticals10/30/2025Reiterated Rating$13.31$20.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals10/29/2025Boost Price Target$654.48$865.00Buy$0.0000.00% ROIORKAOruka Therapeutics10/27/2025Initiated Coverage$27.25$60.00Buy$0.0000.00% ROIRAPTRapt Therapeutics10/27/2025Initiated Coverage$29.53$70.00Buy$0.0000.00% ROILast call for your free 0DTE report (Ad)The 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, protect it. This report normally sells for 29.97, but it's available as a free download for a limited time.Download your free copy of The 0DTE Game Plan before it expiresNMRANeumora Therapeutics10/27/2025Upgrade$2.63$14.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines10/16/2025Set Price Target$189.69$350.00Buy$000.0000.00% ROIABVXAbivax10/10/2025Boost Price Target$90.61$150.00Buy$00.0000.00% ROIACETAdicet Bio10/8/2025Boost Price Target$13.65$128.00Buy$0.0000.00% ROIMLTXMoonLake Immunotherapeutics9/30/2025Lower Price Target$6.24$20.00Buy$00.0000.00% ROIACETAdicet Bio9/19/2025Reiterated Rating$12.97$112.00Buy$0.0000.00% ROIARGXargenex9/18/2025Reiterated Rating$734.77$1,070.00Buy$000.0000.00% ROIROIVRoivant Sciences9/18/2025Boost Price Target$15.42$21.00Buy$00.0000.00% ROITRMLTourmaline Bio9/10/2025Reiterated Rating$47.64$48.00Neutral$0.0000.00% ROITRMLTourmaline Bio9/9/2025Downgrade$47.64Hold$0.0000.00% ROIDNTHDianthus Therapeutics9/9/2025Boost Price Target$31.80$100.00Buy$000.0000.00% ROIFBRXForte Biosciences8/18/2025Initiated Coverage$11.57$75.00Buy$00.0000.00% ROIFBRXForte Biosciences8/18/2025Initiated Coverage$11.49$75.00Buy$00.0000.00% ROITRMLTourmaline Bio8/14/2025Reiterated Rating$21.88$55.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals8/1/2025Boost Price Target$545.46$815.00Buy$000.0000.00% ROINBIXNeurocrine Biosciences8/1/2025Boost Price Target$126.03$175.00Buy$000.0000.00% ROIARGXargenex8/1/2025Boost Price Target$667.75$1,070.00Buy$000.0000.00% ROIABVXAbivax7/23/2025Boost Price Target$10.00$101.00Buy$000.0000.00% ROILRMRLarimar Therapeutics6/24/2025Reiterated Rating$2.42$26.00Buy$0.0000.00% ROIALMSAlumis6/10/2025Upgrade$3.43$18.00Buy$00.0000.00% ROIANABAnaptysBio5/28/2025Reiterated Rating$21.95$90.00Buy$00.0000.00% ROICABACabaletta Bio5/15/2025Boost Price Target$1.70$25.00Buy$0.0000.00% ROIARGXargenex5/9/2025Lower Price Target$547.89$1,065.00Buy$000.0000.00% ROIANABAnaptysBio5/6/2025Boost Price Target$20.97$54.00Buy$00.0000.00% ROINBIXNeurocrine Biosciences5/6/2025Boost Price Target$125.03$165.00Buy$000.0000.00% ROIPHATPhathom Pharmaceuticals5/2/2025Lower Price Target$2.76$12.00Buy$00.0000.00% ROIREGNRegeneron Pharmaceuticals5/1/2025Lower Price Target$589.21$810.00Buy$000.0000.00% ROIPHATPhathom Pharmaceuticals4/2/2025Reiterated Rating$5.98Buy$00.0000.00% ROICABACabaletta Bio4/1/2025Reiterated Rating$1.32$23.00Buy$0.0000.00% ROIZURAZura Bio3/26/2025Reiterated Rating$1.37$15.00Buy$0.0000.00% ROIIFRXInflaRx3/26/2025Boost Price Target$1.33$10.00Buy$0.0000.00% ROILRMRLarimar Therapeutics3/25/2025Reiterated Rating$2.29$26.00Buy$0.0000.00% ROIIMVTImmunovant3/20/2025Reiterated Rating$18.84Buy$00.0000.00% ROIDNTHDianthus Therapeutics3/12/2025Reiterated Rating$23.06$84.00Buy$00.0000.00% ROIARGXargenex3/10/2025Boost Price Target$575.37$1,100.00Buy$000.0000.00% ROIIMVTImmunovant3/10/2025Reiterated Rating$20.28Buy$00.0000.00% ROINMRANeumora Therapeutics3/7/2025Downgrade$1.52Neutral$0.0000.00% ROINBIXNeurocrine Biosciences2/10/2025Lower Price Target$122.62$163.00Buy$000.0000.00% ROIIMVTImmunovant2/10/2025Lower Price Target$20.41$44.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
